Adherence to Therapy in Glaucoma Treatment-A Review
Glaucoma is a chronic disease and the second leading cause of irreversible vision loss worldwide, whose initial treatment consists of self-administered topical ocular hypotensive eyedrops. Adherence with glaucoma medications is a fundamental problem in the care of glaucoma patients as up to 50% of p...
Gespeichert in:
| Veröffentlicht in: | Journal of personalized medicine 2022-03, Vol.12 (4), p.514 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | 514 |
| container_title | Journal of personalized medicine |
| container_volume | 12 |
| creator | Zaharia, Alexandra-Cătălina Dumitrescu, Otilia-Maria Radu, Mădălina Rogoz, Roxana-Elena |
| description | Glaucoma is a chronic disease and the second leading cause of irreversible vision loss worldwide, whose initial treatment consists of self-administered topical ocular hypotensive eyedrops. Adherence with glaucoma medications is a fundamental problem in the care of glaucoma patients as up to 50% of patients fail to receive the intended benefits of the treatment. The literature has identified many barriers to patients' compliance, from factors depending on the type of medication administered, communication between physician and patients, to factors dependent on patients' behaviour and lifestyle. Failure to take medication as prescribed increases the risk that patients will not receive the desired benefit, which often leads to a worsening of the disease. Our aim is to synthesize the methods used for measuring adherence of patients to glaucoma therapy and the interventions used for addressing adherence, laying emphasis on a patient-centred approach, taking time to educate patients about their chronic disease and to assess their views on treatment. |
| doi_str_mv | 10.3390/jpm12040514 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9032050</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2652991544</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-308950701882f68e4355c96e92e5388c7a608ef7bd3804a3bc27e5e306ca34933</originalsourceid><addsrcrecordid>eNpdkc1Lw0AQxRdRbKk9eZeAF0Gis1_J7kUoRatQEKSel-12YlOSbN0klf73prRKdS4zMD8eb-YRcknhjnMN96t1SRkIkFSckD6DVMZCsOT0aO6RYV2voCslGUvgnPS4FFImHPqEjxZLDFg5jBofzbrZrrdRXkWTwrbOlzaaBbRNiVUTj6I33OT4dUHOMlvUODz0AXl_epyNn-Pp6-RlPJrGToBuYg5KS0iBKsWyRKHgUjqdoGYouVIutQkozNL5gisQls8dS1Eih8RZLjTnA_Kw11238xIXrvMQbGHWIS9t2Bpvc_N3U-VL8-E3RgNnIKETuDkIBP_ZYt2YMq8dFoWt0Le1YYkUTFHJaIde_0NXvg1Vd96OYlpTKURH3e4pF3xdB8x-zVAwuzzMUR4dfXXs_5f9-T7_BtDzgxk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2652991544</pqid></control><display><type>article</type><title>Adherence to Therapy in Glaucoma Treatment-A Review</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Zaharia, Alexandra-Cătălina ; Dumitrescu, Otilia-Maria ; Radu, Mădălina ; Rogoz, Roxana-Elena</creator><creatorcontrib>Zaharia, Alexandra-Cătălina ; Dumitrescu, Otilia-Maria ; Radu, Mădălina ; Rogoz, Roxana-Elena</creatorcontrib><description>Glaucoma is a chronic disease and the second leading cause of irreversible vision loss worldwide, whose initial treatment consists of self-administered topical ocular hypotensive eyedrops. Adherence with glaucoma medications is a fundamental problem in the care of glaucoma patients as up to 50% of patients fail to receive the intended benefits of the treatment. The literature has identified many barriers to patients' compliance, from factors depending on the type of medication administered, communication between physician and patients, to factors dependent on patients' behaviour and lifestyle. Failure to take medication as prescribed increases the risk that patients will not receive the desired benefit, which often leads to a worsening of the disease. Our aim is to synthesize the methods used for measuring adherence of patients to glaucoma therapy and the interventions used for addressing adherence, laying emphasis on a patient-centred approach, taking time to educate patients about their chronic disease and to assess their views on treatment.</description><identifier>ISSN: 2075-4426</identifier><identifier>EISSN: 2075-4426</identifier><identifier>DOI: 10.3390/jpm12040514</identifier><identifier>PMID: 35455630</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Chronic illnesses ; Compliance ; Drug dosages ; Glaucoma ; Patients ; Physicians ; Precision medicine ; Prescription drugs ; Quality of life ; Questionnaires ; Review</subject><ispartof>Journal of personalized medicine, 2022-03, Vol.12 (4), p.514</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-308950701882f68e4355c96e92e5388c7a608ef7bd3804a3bc27e5e306ca34933</citedby><cites>FETCH-LOGICAL-c409t-308950701882f68e4355c96e92e5388c7a608ef7bd3804a3bc27e5e306ca34933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032050/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032050/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,27907,27908,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35455630$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zaharia, Alexandra-Cătălina</creatorcontrib><creatorcontrib>Dumitrescu, Otilia-Maria</creatorcontrib><creatorcontrib>Radu, Mădălina</creatorcontrib><creatorcontrib>Rogoz, Roxana-Elena</creatorcontrib><title>Adherence to Therapy in Glaucoma Treatment-A Review</title><title>Journal of personalized medicine</title><addtitle>J Pers Med</addtitle><description>Glaucoma is a chronic disease and the second leading cause of irreversible vision loss worldwide, whose initial treatment consists of self-administered topical ocular hypotensive eyedrops. Adherence with glaucoma medications is a fundamental problem in the care of glaucoma patients as up to 50% of patients fail to receive the intended benefits of the treatment. The literature has identified many barriers to patients' compliance, from factors depending on the type of medication administered, communication between physician and patients, to factors dependent on patients' behaviour and lifestyle. Failure to take medication as prescribed increases the risk that patients will not receive the desired benefit, which often leads to a worsening of the disease. Our aim is to synthesize the methods used for measuring adherence of patients to glaucoma therapy and the interventions used for addressing adherence, laying emphasis on a patient-centred approach, taking time to educate patients about their chronic disease and to assess their views on treatment.</description><subject>Chronic illnesses</subject><subject>Compliance</subject><subject>Drug dosages</subject><subject>Glaucoma</subject><subject>Patients</subject><subject>Physicians</subject><subject>Precision medicine</subject><subject>Prescription drugs</subject><subject>Quality of life</subject><subject>Questionnaires</subject><subject>Review</subject><issn>2075-4426</issn><issn>2075-4426</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkc1Lw0AQxRdRbKk9eZeAF0Gis1_J7kUoRatQEKSel-12YlOSbN0klf73prRKdS4zMD8eb-YRcknhjnMN96t1SRkIkFSckD6DVMZCsOT0aO6RYV2voCslGUvgnPS4FFImHPqEjxZLDFg5jBofzbrZrrdRXkWTwrbOlzaaBbRNiVUTj6I33OT4dUHOMlvUODz0AXl_epyNn-Pp6-RlPJrGToBuYg5KS0iBKsWyRKHgUjqdoGYouVIutQkozNL5gisQls8dS1Eih8RZLjTnA_Kw11238xIXrvMQbGHWIS9t2Bpvc_N3U-VL8-E3RgNnIKETuDkIBP_ZYt2YMq8dFoWt0Le1YYkUTFHJaIde_0NXvg1Vd96OYlpTKURH3e4pF3xdB8x-zVAwuzzMUR4dfXXs_5f9-T7_BtDzgxk</recordid><startdate>20220322</startdate><enddate>20220322</enddate><creator>Zaharia, Alexandra-Cătălina</creator><creator>Dumitrescu, Otilia-Maria</creator><creator>Radu, Mădălina</creator><creator>Rogoz, Roxana-Elena</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220322</creationdate><title>Adherence to Therapy in Glaucoma Treatment-A Review</title><author>Zaharia, Alexandra-Cătălina ; Dumitrescu, Otilia-Maria ; Radu, Mădălina ; Rogoz, Roxana-Elena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-308950701882f68e4355c96e92e5388c7a608ef7bd3804a3bc27e5e306ca34933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Chronic illnesses</topic><topic>Compliance</topic><topic>Drug dosages</topic><topic>Glaucoma</topic><topic>Patients</topic><topic>Physicians</topic><topic>Precision medicine</topic><topic>Prescription drugs</topic><topic>Quality of life</topic><topic>Questionnaires</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zaharia, Alexandra-Cătălina</creatorcontrib><creatorcontrib>Dumitrescu, Otilia-Maria</creatorcontrib><creatorcontrib>Radu, Mădălina</creatorcontrib><creatorcontrib>Rogoz, Roxana-Elena</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of personalized medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zaharia, Alexandra-Cătălina</au><au>Dumitrescu, Otilia-Maria</au><au>Radu, Mădălina</au><au>Rogoz, Roxana-Elena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adherence to Therapy in Glaucoma Treatment-A Review</atitle><jtitle>Journal of personalized medicine</jtitle><addtitle>J Pers Med</addtitle><date>2022-03-22</date><risdate>2022</risdate><volume>12</volume><issue>4</issue><spage>514</spage><pages>514-</pages><issn>2075-4426</issn><eissn>2075-4426</eissn><abstract>Glaucoma is a chronic disease and the second leading cause of irreversible vision loss worldwide, whose initial treatment consists of self-administered topical ocular hypotensive eyedrops. Adherence with glaucoma medications is a fundamental problem in the care of glaucoma patients as up to 50% of patients fail to receive the intended benefits of the treatment. The literature has identified many barriers to patients' compliance, from factors depending on the type of medication administered, communication between physician and patients, to factors dependent on patients' behaviour and lifestyle. Failure to take medication as prescribed increases the risk that patients will not receive the desired benefit, which often leads to a worsening of the disease. Our aim is to synthesize the methods used for measuring adherence of patients to glaucoma therapy and the interventions used for addressing adherence, laying emphasis on a patient-centred approach, taking time to educate patients about their chronic disease and to assess their views on treatment.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35455630</pmid><doi>10.3390/jpm12040514</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2075-4426 |
| ispartof | Journal of personalized medicine, 2022-03, Vol.12 (4), p.514 |
| issn | 2075-4426 2075-4426 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9032050 |
| source | PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Chronic illnesses Compliance Drug dosages Glaucoma Patients Physicians Precision medicine Prescription drugs Quality of life Questionnaires Review |
| title | Adherence to Therapy in Glaucoma Treatment-A Review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T05%3A13%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adherence%20to%20Therapy%20in%20Glaucoma%20Treatment-A%20Review&rft.jtitle=Journal%20of%20personalized%20medicine&rft.au=Zaharia,%20Alexandra-C%C4%83t%C4%83lina&rft.date=2022-03-22&rft.volume=12&rft.issue=4&rft.spage=514&rft.pages=514-&rft.issn=2075-4426&rft.eissn=2075-4426&rft_id=info:doi/10.3390/jpm12040514&rft_dat=%3Cproquest_pubme%3E2652991544%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2652991544&rft_id=info:pmid/35455630&rfr_iscdi=true |